Company Overview
GoodRx Holdings, Inc. operates within the healthcare sector, specifically serving the health information services industry by providing consumers with tools to compare prescription drug prices and save on costs in the United States. The company's business model centers on a price comparison platform that delivers curated, geographically relevant information to facilitate savings on medication purchases. In terms of scale, GoodRx Holdings, Inc. carries a market capitalization of $698.85M and reported annual revenue of $796.85M over the trailing twelve months while employing 697 individuals. These financial figures indicate that the company has established a significant operational footprint, managing nearly three-quarters of a billion dollars in revenue with a market valuation under one billion dollars, which suggests a mid-cap position in the competitive health information services landscape.
Financial Health
The company generated revenue of $796.85M, recorded net income of $30.44M, and achieved an EBITDA of $122.31M, revealing a substantial gap between top-line revenue and bottom-line profit. This disparity highlights a cost structure where operating expenses, including cost of goods sold and administrative costs, consume approximately 96.2% of revenue before reaching the net income figure. The free cash flow stands at $81.94M, which demonstrates a strong ability to generate cash from operations relative to capital expenditures, providing the company with significant financial flexibility for potential strategic initiatives or debt servicing. Margin analysis shows a gross margin of 92.8%, indicating highly efficient pricing power or low direct costs of providing the digital platform; an operating margin of 19.0% reflects the efficiency of the core business operations after overhead; and a profit margin of 3.8% illustrates the final profitability after all expenses, taxes, and interest. On the balance sheet, total cash resources of $261.82M are compared against total debt of $542.81M, resulting in a debt-to-equity ratio of 88.08, which characterizes a leveraged balance sheet where liabilities significantly exceed equity. Despite the leverage, the current ratio of 2.61 indicates robust short-term liquidity, as the company holds more than twice the assets required to cover its current liabilities. Return metrics further define financial performance, with a return on equity of 4.5% and a return on assets of 4.8%, suggesting that management is generating modest returns relative to the capital invested and the asset base utilized.
Valuation Assessment
Valuation metrics reveal a trailing P/E ratio of 22.67 compared to a forward P/E of 5.49, implying that the market expects earnings to grow significantly in the future to justify the current high multiple based on historical performance. The price-to-book ratio is 1.13, which indicates that the company is trading at a slight premium over its book value, suggesting investors value the brand and platform beyond the tangible assets recorded on the books. Alternative valuation measures include a price-to-sales ratio of 0.88 and an EV/EBITDA of 8.01, suggesting the company is priced at less than one dollar of revenue per dollar of sales and at a multiple of roughly eight times its earnings before interest, taxes, depreciation, and amortization. Regarding price range, the stock has a 52-week high of $5.81 and a 52-week low of $1.77, providing the context that the current trading price sits within a wide historical band defined by these extremes. The beta value is 1.56, which means the stock price is expected to be 56% more volatile than the broader market, indicating higher sensitivity to market swings compared to a standard equity index.
Growth & Income
Recent performance data shows revenue growth of -1.9% and earnings growth of -9.7% year over year, indicating that earnings are contracting at a faster rate than revenue, which may suggest rising cost pressures or margin compression affecting profitability more severely than top-line sales. As the company does not pay a dividend, there is a dividend yield of N/A and a payout ratio of 0.0%, meaning the company retains all its earnings rather than distributing them to shareholders. This lack of dividend payments aligns with the strategy of reinvesting earnings into growth initiatives, operational expansion, or debt reduction rather than providing current income to investors. The overall growth and income profile is characterized by negative growth rates in both revenue and earnings, combined with a non-dividend policy that focuses capital retention and balance sheet management over shareholder distribution.